P&G HYGIENE & HEALTH CARE

Procter & Gamble Hygiene and Health Care Limited held an earnings call on June 16, 2026, where management discussed the company's financial performance for the fiscal year ending March 31, 2026. The company reported sales of approximately 4300 crores, remaining flat compared to the previous year, while Profit After Tax (PAT) increased by 19% to about 850 crores. Management highlighted a focus on consumer-centric innovation and strengthening go-to-market capabilities. They acknowledged challenges such as media fragmentation, inflation, and evolving retail landscapes. The call emphasized the importance of an integrated growth strategy, which includes delivering superior products, enhancing productivity, and fostering constructive disruption. Management also noted the success of specific product lines, including Whisper Period Panties and Vicks Cough Syrup, and discussed ongoing efforts to adapt to changing consumer preferences and competitive pressures. The session concluded with a Q&A segment addressing various industry trends and company strategies.

Management reported mixed results, highlighting both challenges and successes in their strategies.